Share your experiences with us

Page1 / 5
20% of survey complete.
Our biomarker initiative is aimed developing a test that can measure whether a drug has blocked DUX4 (the root cause of FSHD) by looking at DNA from blood rather than from a muscle biopsy. Having this biomarker assay will make clinical research and trials faster, cheaper, and more accurate.

Question Title

* 1. Have you ever had a muscle biopsy, and if so, how many?